On the public citation graph

Duodenal Toxicity After Fractionated Chemoradiation for Unresectable Pancreatic Cancer

https://doi.org/10.1016/j.ijrobp.2012.09.035
0 signed · 109 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1097-0142(20001201)89:11<2222::aid-cncr10>3.0.co;2-vopenalex-snapshot
Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma
inferredcites →https://doi.org/10.1002/cncr.22735openalex-snapshot
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
inferredcites →https://doi.org/10.1016/0167-8140(88)90299-xopenalex-snapshot
Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: Emphasis on the role of exploratory laparotomy and fractionation
inferredcites →https://doi.org/10.1016/0360-3016(91)90171-yopenalex-snapshot
Tolerance of normal tissue to therapeutic irradiation
inferredcites →https://doi.org/10.1016/j.ijrobp.2009.05.071openalex-snapshot
Radiation Dose–Volume Effects in the Stomach and Small Bowel
inferredcites →https://doi.org/10.1016/j.ijrobp.2009.09.040openalex-snapshot
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues
inferredcites →https://doi.org/10.1016/j.ijrobp.2009.09.075openalex-snapshot
A Dosimetric Model of Duodenal Toxicity After Stereotactic Body Radiotherapy for Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2010.05.006openalex-snapshot
Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1016/j.ijrobp.2011.09.022openalex-snapshot
Dose–Volume Analysis of Predictors for Gastrointestinal Toxicity After Concurrent Full-Dose Gemcitabine and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma
inferredcites →https://doi.org/10.1016/j.ijrobp.2011.12.026openalex-snapshot
Analysis of Dosimetric Parameters Associated With Acute Gastrointestinal Toxicity and Upper Gastrointestinal Bleeding in Locally Advanced Pancreatic Cancer Patients Treated With Gemcitabine-Based Concurrent Chemoradiotherapy
inferredcites →https://doi.org/10.1016/j.radonc.2009.05.017openalex-snapshot
Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/s0360-3016(01)02740-7openalex-snapshot
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
inferredcites →https://doi.org/10.1016/s0360-3016(03)00435-8openalex-snapshot
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study
inferredcites →https://doi.org/10.1093/annonc/mdn281openalex-snapshot
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
inferredcites →https://doi.org/10.1097/01.ede.0000147512.81966.baopenalex-snapshot
Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood Samples
inferredcites →https://doi.org/10.1097/01.sla.0000152016.40331.bbopenalex-snapshot
Long-term Results of Intraoperative Electron Beam Irradiation (IOERT) for Patients With Unresectable Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2007.12.0592openalex-snapshot
Phase I Study of Oxaliplatin, Full-Dose Gemcitabine, and Concurrent Radiation Therapy in Pancreatic Cancer
inferredcites →https://doi.org/10.1200/jco.2010.33.8038openalex-snapshot
Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression
inferredcites →https://doi.org/10.1200/jco.2011.34.8904openalex-snapshot
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4706360openalex-extracted
Standard or High Dose Chemoradiotherapy, with or Without the Protease Inhibitor Nelfinavir, for the Treatment of Locally Advanced Pancreatic Cancer: Efficacy, Safety and Health-Related Quality of Life Outcomes from the Multi-Centre Two Stage Phase 1/Randomised Phase 2 SCALOP-2 Study
inferred← citeshttps://doi.org/10.1002/9781119707530.ch19openalex-snapshot
Hepatobiliary Cancers
inferred← citeshttps://doi.org/10.1002/acm2.13137openalex-snapshot
Accuracy and efficiency of respiratory gating comparable to deep inspiration breath hold for pancreatic cancer treatment
inferred← citeshttps://doi.org/10.1002/acm2.13740openalex-snapshot
Intrafractional accuracy and efficiency of a surface imaging system for deep inspiration breath hold during ablative gastrointestinal cancer treatment
inferred← citeshttps://doi.org/10.1002/acm2.14155openalex-snapshot
Deep learning in MRI‐guided radiation therapy: A systematic review
inferred← citeshttps://doi.org/10.1002/acm2.70401openalex-snapshot
Organ‐specific equivalent uniform dose constraints and radiobiological parameters for radiation treatment planning of abdominal tumors
inferred← citeshttps://doi.org/10.1002/cam4.4418openalex-snapshot
A modified delineation method of para‐aortic nodal clinical target volume in patients with locally advanced cervical cancer
inferred← citeshttps://doi.org/10.1002/cncr.29878openalex-snapshot
Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance
inferred← citeshttps://doi.org/10.1002/jmrs.703openalex-snapshot
Impact of bowel space contouring variability on radiation dose and volume assessments in treatment planning for gynaecologic cancers
inferred← citeshttps://doi.org/10.1002/mp.13857openalex-snapshot
Assessing localized dosimetric effects due to unplanned gas cavities during pelvic MR‐guided radiotherapy using Monte Carlo simulations
inferred← citeshttps://doi.org/10.1002/smll.201906915openalex-snapshot
Clinically Approved Carbon Nanoparticles with Oral Administration for Intestinal Radioprotection via Protecting the Small Intestinal Crypt Stem Cells and Maintaining the Balance of Intestinal Flora
inferred← citeshttps://doi.org/10.1007/174_2013_870openalex-snapshot
Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-01443-8_6openalex-snapshot
Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy
inferred← citeshttps://doi.org/10.1007/978-3-030-37798-4_5openalex-snapshot
Toxicity Management for Upper Abdomen Tumors in Radiation Oncology
inferred← citeshttps://doi.org/10.1007/978-3-319-98944-0_11openalex-snapshot
Role of Radiation for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1007/s00066-014-0759-1openalex-snapshot
Role of radiotherapy in the chemotherapy-containing multidisciplinary management of patients with resected pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.1007/s00066-018-01420-7openalex-snapshot
Clinical safety and efficacy of salvage reirradiation for upper abdominal malignancies
inferred← citeshttps://doi.org/10.1007/s00259-023-06430-xopenalex-snapshot
Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse model
inferred← citeshttps://doi.org/10.1007/s10147-020-01662-5openalex-snapshot
Management of gastrointestinal perforation related to radiation
inferred← citeshttps://doi.org/10.1007/s11307-014-0755-yopenalex-snapshot
Dose-Dependent Uptake of 3′-deoxy-3′-[18 F]Fluorothymidine by the Bowel after Total-Body Irradiation
inferred← citeshttps://doi.org/10.1007/s11547-021-01441-wopenalex-snapshot
A non-surgical COMBO-therapy approach for locally advanced unresectable pancreatic adenocarcinoma: preliminary results of a prospective study
inferred← citeshttps://doi.org/10.1007/s12094-024-03460-1openalex-snapshot
Evolution of radiation-induced dermatitis treatment
inferred← citeshttps://doi.org/10.1007/s13566-020-00427-xopenalex-snapshot
Lymph node–directed simultaneous integrated boost in patients with clinically lymph node–positive cervical cancer treated with definitive chemoradiotherapy: clinical outcomes and toxicity
inferred← citeshttps://doi.org/10.1016/b978-0-323-24098-7.00014-9openalex-snapshot
Late Effects after Radiation
inferred← citeshttps://doi.org/10.1016/b978-0-323-24098-7.00048-4openalex-snapshot
Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/b978-84-9113-949-2.00041-xopenalex-snapshot
10.1016/b978-84-9113-949-2.00041-x
inferred← citeshttps://doi.org/10.1016/j.adro.2017.09.005openalex-snapshot
Late small bowel toxicity after aggressive abdominopelvic intensity modulated radiation therapy
inferred← citeshttps://doi.org/10.1016/j.canrad.2021.11.001openalex-snapshot
Organs at risk radiation dose constraints
inferred← citeshttps://doi.org/10.1016/j.canrad.2026.104805openalex-snapshot
Radiotherapy and brachytherapy in the management of adult soft tissue sarcomas
inferred← citeshttps://doi.org/10.1016/j.cej.2021.131725openalex-snapshot
Fullerenol@nano-montmorillonite nanocomposite as an efficient radioprotective agent for ameliorating radioactive duodenal injury
inferred← citeshttps://doi.org/10.1016/j.clon.2014.06.009openalex-snapshot
The Application of Functional Imaging Techniques to Personalise Chemoradiotherapy in Upper Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1016/j.clon.2017.01.038openalex-snapshot
Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
inferred← citeshttps://doi.org/10.1016/j.clon.2018.02.067openalex-snapshot
Stomach Dose–Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2019.08.003openalex-snapshot
A Retrospective Study of the Dosimetric Parameters and Duodenal Toxicity in Patients With Upper Gastrointestinal and Gynaecological Cancers Treated With Radiation Therapy
inferred← citeshttps://doi.org/10.1016/j.clon.2020.08.009openalex-snapshot
Regional Control and Chemoradiotherapy Dose Response for Clinically Involved Lymph Nodes in Patients with Locally Advanced Endometrial Cancers Who are Not Candidates for Upfront Surgical Staging Extrafascial Hysterectomy
inferred← citeshttps://doi.org/10.1016/j.ctro.2022.03.003openalex-snapshot
Cetuximab, gemcitabine and radiotherapy in locally advanced pancreatic cancer: Long-term results of the randomized controlled phase II PARC trial
inferred← citeshttps://doi.org/10.1016/j.ctro.2022.04.007openalex-snapshot
Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
inferred← citeshttps://doi.org/10.1016/j.ejca.2024.114236openalex-snapshot
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2013.09.042openalex-snapshot
In Reply to Bahl et al
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2013.09.044openalex-snapshot
In Regard to Kelly et al
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2013.09.053openalex-snapshot
Dosimetric Predictors of Duodenal Toxicity After Intensity Modulated Radiation Therapy for Treatment of the Para-aortic Nodes in Gynecologic Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2015.02.015openalex-snapshot
Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer
inferred← citeshttps://doi.org/10.1016/j.prro.2013.05.003openalex-snapshot
Consolidating duodenal and small bowel toxicity data via isoeffective dose calculations based on compiled clinical data
inferred← citeshttps://doi.org/10.1016/j.prro.2014.10.013openalex-snapshot
Extended field intensity modulated radiation therapy for gynecologic cancers: Is the risk of duodenal toxicity high?
inferred← citeshttps://doi.org/10.1016/j.prro.2021.08.002openalex-snapshot
Higher Dose to Organs at Risk: The Unintended Consequences of Intravenous Contrast Use in Computed Tomography Simulation for Cervical Cancer
inferred← citeshttps://doi.org/10.1016/j.prro.2021.12.008openalex-snapshot
Use of Specific Duodenal Dose Constraints During Treatment Planning Reduces Toxicity After Definitive Paraaortic Radiation Therapy for Cervical Cancer
inferred← citeshttps://doi.org/10.1016/j.radmp.2026.03.004openalex-snapshot
Prescription tradeoff decision support for pancreas stereotactic body radiation therapy: From templates to artificial intelligence models
inferred← citeshttps://doi.org/10.1016/j.radonc.2016.12.030openalex-snapshot
Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial
inferred← citeshttps://doi.org/10.1016/j.radonc.2017.04.024openalex-snapshot
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
inferred← citeshttps://doi.org/10.1016/j.scrs.2020.100763openalex-snapshot
The use of intraoperative radiation therapy in the management of locally recurrent rectal cancer
inferred← citeshttps://doi.org/10.1016/j.ygyno.2015.07.096openalex-snapshot
Management of nodal recurrences of endometrial cancer with IMRT
inferred← citeshttps://doi.org/10.1038/s41598-018-35402-7openalex-snapshot
Evaluation of Dynamic Tumor-tracking Intensity-modulated Radiotherapy for Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.1055/s-0039-3402429openalex-snapshot
The Role of Platelets in Cancer-Related Bleeding Risk: A Systematic Review
inferred← citeshttps://doi.org/10.1080/0284186x.2016.1257863openalex-snapshot
Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows only limited dosimetric benefit
inferred← citeshttps://doi.org/10.1080/0284186x.2020.1742931openalex-snapshot
Daily dose to organs at risk predicts acute toxicity in pancreatic stereotactic radiotherapy
inferred← citeshttps://doi.org/10.1088/1361-6560/abcd1bopenalex-snapshot
Statistical shape model-based planning organ-at-risk volume: application to pancreatic cancer patients
inferred← citeshttps://doi.org/10.1093/jjco/hyw205openalex-snapshot
Predictive factors of gastroduodenal bleeding after postoperative radiotherapy in biliary tract cancer
inferred← citeshttps://doi.org/10.1093/jrr/rrac049openalex-snapshot
Comparison of acute gastrointestinal toxicities between 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy including prophylactic regions in chemoradiotherapy with S-1 for pancreatic cancer—importance of dose volume histogram parameters in the stomach as the predictive…
inferred← citeshttps://doi.org/10.1093/jrr/rrw016openalex-snapshot
Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1097/coc.0000000000000118openalex-snapshot
Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.1097/coc.0000000000000200openalex-snapshot
Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1097/md.0000000000038469openalex-snapshot
Gastroscopic observation and dose-volume histogram parameter study on gastrointestinal mucous injury for pancreatic cancer treated with TOMO
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000292openalex-snapshot
Ablative Radiotherapy Doses for Locally Advanced
inferred← citeshttps://doi.org/10.1118/1.4887797openalex-snapshot
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas
inferred← citeshttps://doi.org/10.1118/1.4964790openalex-snapshot
Unwrapping 3D complex hollow organs for spatial dose surface analysis
inferred← citeshttps://doi.org/10.1158/0008-5472.can-18-1785openalex-snapshot
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer
inferred← citeshttps://doi.org/10.1186/1748-717x-9-146openalex-snapshot
Challenges in using 18 F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1186/s13014-017-0945-2openalex-snapshot
Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
inferred← citeshttps://doi.org/10.1186/s13014-019-1262-8openalex-snapshot
A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy
inferred← citeshttps://doi.org/10.1186/s13014-019-1309-xopenalex-snapshot
Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results
inferred← citeshttps://doi.org/10.1186/s13014-019-1398-6openalex-snapshot
Reduction of dose to duodenum with a refined delineation method of Para-aortic region in patients with locally advanced cervical Cancer receiving prophylactic extended-field radiotherapy
inferred← citeshttps://doi.org/10.1186/s13014-020-01592-6openalex-snapshot
Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head
inferred← citeshttps://doi.org/10.1245/s10434-017-6098-6openalex-snapshot
Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma
inferred← citeshttps://doi.org/10.1259/bjr.20150661openalex-snapshot
Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan
inferred← citeshttps://doi.org/10.1259/bjr.20190101openalex-snapshot
Beam direction arrangement using a superconducting rotating gantry in carbon ion treatment for pancreatic cancer
inferred← citeshttps://doi.org/10.1371/journal.pone.0186341openalex-snapshot
Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
inferred← citeshttps://doi.org/10.14338/ijpt.14-00006.1openalex-snapshot
Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma
inferred← citeshttps://doi.org/10.21037/5996openalex-snapshot
The expanding role of stereotactic body radiation therapy for pancreatic cancer: a review of the literature
inferred← citeshttps://doi.org/10.21037/jgo-20-245openalex-snapshot
Chemoradiotherapy for patients with locally advanced or unresectable extra-hepatic biliary cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-60459/v1openalex-snapshot
Dosimetric benefits of dynamic wave arc over co-planar volumetric modulated radiotherapy for locally advanced pancreatic cancer
inferred← citeshttps://doi.org/10.2147/ott.s102035openalex-snapshot
Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma
inferred← citeshttps://doi.org/10.23889/suthesis.64844openalex-snapshot
Monte Carlo Modelling for Photon and Proton Therapy in Heterogenous Tissue and Prosthesis Material
inferred← citeshttps://doi.org/10.3389/fonc.2020.517061openalex-snapshot
Dose–Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis
inferred← citeshttps://doi.org/10.3389/fonc.2021.747532openalex-snapshot
Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy
inferred← citeshttps://doi.org/10.3389/fonc.2021.769385openalex-snapshot
HIF2 Regulates Intestinal Wnt5a Expression
inferred← citeshttps://doi.org/10.3389/fonc.2022.983984openalex-snapshot
Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy
inferred← citeshttps://doi.org/10.3390/cancers13184733openalex-snapshot
The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
inferred← citeshttps://doi.org/10.3390/cancers17020202openalex-snapshot
Current Paradigm and Future Directions in the Management of Nodal Disease in Locally Advanced Cervical Cancer
inferred← citeshttps://doi.org/10.3390/curroncol30120756openalex-snapshot
Risk Factors for Nodal Failure in Patients with FIGO IIIC Cervical Cancer Receiving Definitive Image-Guided Radiotherapy
inferred← citeshttps://doi.org/10.6084/m9.figshare.12544574openalex-snapshot
Additional file 6 of Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.